GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (BSP:E1WL34) » Definitions » Cyclically Adjusted PS Ratio

Edwards Lifesciences (BSP:E1WL34) Cyclically Adjusted PS Ratio : 11.50 (As of May. 03, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Edwards Lifesciences Cyclically Adjusted PS Ratio?

As of today (2024-05-03), Edwards Lifesciences's current share price is R$108.68. Edwards Lifesciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was R$9.45. Edwards Lifesciences's Cyclically Adjusted PS Ratio for today is 11.50.

The historical rank and industry rank for Edwards Lifesciences's Cyclically Adjusted PS Ratio or its related term are showing as below:

BSP:E1WL34' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.07   Med: 12.84   Max: 23.68
Current: 11.31

During the past years, Edwards Lifesciences's highest Cyclically Adjusted PS Ratio was 23.68. The lowest was 5.07. And the median was 12.84.

BSP:E1WL34's Cyclically Adjusted PS Ratio is ranked worse than
89.03% of 474 companies
in the Medical Devices & Instruments industry
Industry Median: 2.155 vs BSP:E1WL34: 11.31

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Edwards Lifesciences's adjusted revenue per share data for the three months ended in Mar. 2024 was R$13.175. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is R$9.45 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Edwards Lifesciences Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Edwards Lifesciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Cyclically Adjusted PS Ratio Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.30 19.16 22.91 11.40 10.36

Edwards Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.16 13.42 9.57 10.36 12.71

Competitive Comparison of Edwards Lifesciences's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted PS Ratio falls into.



Edwards Lifesciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Edwards Lifesciences's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=108.68/9.45
=11.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Edwards Lifesciences's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=13.175/129.4194*129.4194
=13.175

Current CPI (Mar. 2024) = 129.4194.

Edwards Lifesciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.996 100.560 2.569
201409 2.183 100.428 2.813
201412 2.481 99.070 3.241
201503 2.802 99.621 3.640
201506 2.909 100.684 3.739
201509 3.642 100.392 4.695
201512 3.930 99.792 5.097
201603 3.946 100.470 5.083
201606 3.987 101.688 5.074
201609 3.676 101.861 4.671
201612 3.935 101.863 5.000
201703 4.256 102.862 5.355
201706 4.287 103.349 5.368
201709 3.968 104.136 4.931
201712 4.533 104.011 5.640
201803 4.547 105.290 5.589
201806 5.543 106.317 6.747
201809 5.824 106.507 7.077
201812 5.963 105.998 7.281
201903 5.991 107.251 7.229
201906 6.587 108.070 7.888
201909 7.083 108.329 8.462
201912 7.555 108.420 9.018
202003 8.684 108.902 10.320
202006 7.737 108.767 9.206
202009 9.764 109.815 11.507
202012 9.562 109.897 11.261
202103 10.860 111.754 12.577
202106 10.985 114.631 12.402
202109 10.949 115.734 12.244
202112 11.901 117.630 13.094
202203 10.604 121.301 11.314
202206 11.066 125.017 11.456
202209 11.075 125.227 11.446
202212 11.479 125.222 11.864
202303 12.445 127.348 12.647
202306 12.170 128.729 12.235
202309 12.000 129.860 11.959
202312 12.383 129.419 12.383
202403 13.175 129.419 13.175

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Edwards Lifesciences  (BSP:E1WL34) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Edwards Lifesciences Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences (BSP:E1WL34) Business Description

Traded in Other Exchanges
Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (BSP:E1WL34) Headlines

No Headlines